5 Updates in Neurology

COMMENTARY

5 Updates in Neurology

Hans-Christoph Diener, MD, PhD

Disclosures

January 20, 2021

2

This transcript has been edited for clarity.

Dear colleagues, I'm Christoph Diener from the University of Duisburg-Essen in Germany, here to tell you about five interesting neurology studies published in December 2020.

The first study of interest is in neuro-traumatology. People with subdural hematomas are usually treated by surgery. However, there is a hypothesis that perhaps dexamethasone could have an impact on the outcome of this condition, given the presence of inflammation within the dura and leakage of small vessels in chronic subdural hematoma.

In a study published in The New England Journal of Medicine, UK investigators randomized 748 patients with symptomatic chronic subdural hematoma to either dexamethasone or placebo. Of the patients, 94% underwent surgery. The primary outcome was a modified Rankin score between 0 and 3, which was achieved in 84% of patients on dexamethasone vs 90% on placebo, meaning placebo was superior to dexamethasone (P = .01). In conclusion, there is no indication to use corticosteroids in patients with chronic subdural hematoma.

The second study investigated the prehospital use of tranexamic acid in patients with severe traumatic brain injurywho were flown by helicopter to a trauma center. Data were analyzed from a registry in the Netherlands, with a primary endpoint of 30-day mortality.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....